Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2208966
Abstract: AIMS The diagnostic history in the years leading up to the definitive diagnosis of patients with obstructive hypertrophic cardiomyopathy (HCM) has not been studied. METHODS Patients with a delay in the definitive diagnosis of obstructive… read more here.
Keywords: hypertrophic cardiomyopathy; obstructive hcm; obstructive hypertrophic; diagnosis ... See more keywords
A comprehensive evaluation of available evidence of mavacamten in obstructive HCM: a meta-analysis of randomised controlled trials
Sign Up to like & getrecommendations! Published in 2024 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehae666.2048
Abstract: Obstructive hypertrophic cardiomyopathy (HCM) poses a significant clinical challenge, characterized by left ventricular hypertrophy and impaired cardiac function. mavacamten, a novel medication targeting the sarcomere protein myosin, has emerged as a promising therapeutic option for… read more here.
Keywords: obstructive hcm; controlled trials; evaluation available; comprehensive evaluation ... See more keywords
Post-carvedilol myocardial function in cats with obstructive hypertrophic cardiomyopathy
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Veterinary Science"
DOI: 10.3389/fvets.2025.1571850
Abstract: Introduction Hypertrophic cardiomyopathy (HCM) is the most prevalent cardiac disease in cats, and one phenotype includes obstructive HCM with dynamic left ventricular outflow tract obstruction (DLVOTO). Myocardial function has been reported to be lower in… read more here.
Keywords: carvedilol; myocardial function; obstructive hcm; cats obstructive ... See more keywords